According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:
1. Omnicell (NASDAQ:OMCL)
Omnicell (NASDAQ:OMCL) is the #1 top health information service stock out of 50 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year.
Learn more.
The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.
Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 57, which is 25 points higher than the health information service industry average of 32.
OMCL passed 18 out of 33 due diligence checks and has strong fundamentals. Omnicell has seen its stock return 12.07% over the past year, overperforming other health information service stocks by 67 percentage points.
Omnicell has an average 1 year
price target of $53.33, an upside of 58.73% from Omnicell's current stock price of $33.60.
Omnicell stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Omnicell, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Progyny (NASDAQ:PGNY)
Progyny (NASDAQ:PGNY) is the #2 top health information service stock out of 50 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year.
Learn more.
The Component Grade breakdown for Progyny (NASDAQ:PGNY) is: Value: C, Growth: B, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.
Progyny (NASDAQ:PGNY) has a Due Diligence Score of 61, which is 29 points higher than the health information service industry average of 32.
PGNY passed 20 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock return 22.77% over the past year, overperforming other health information service stocks by 77 percentage points.
Progyny has an average 1 year
price target of $33.50, an upside of 32.78% from Progyny's current stock price of $25.23.
Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Progyny, 70% have issued a Strong Buy rating, 10% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Carecloud (NASDAQ:CCLD)
Carecloud (NASDAQ:CCLD) is the #3 top health information service stock out of 50 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year.
Learn more.
The Component Grade breakdown for Carecloud (NASDAQ:CCLD) is: Value: A, Growth: C, Momentum: D, Sentiment: C, Safety: B, Financials: B, and AI: C.
Carecloud (NASDAQ:CCLD) has a Due Diligence Score of 47, which is 15 points higher than the health information service industry average of 32.
CCLD passed 15 out of 33 due diligence checks and has strong fundamentals. Carecloud has seen its stock lose -39.16% over the past year, overperforming other health information service stocks by 15 percentage points.